AARON M LAINE
Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology WEATHERFORD, TX NPI 1003058900
Browse related groups: Allopathic & Osteopathic Physicians|Radiology|Radiation Oncology TX NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$3,895.77
- Category: General Payments
- Program years: PY2018–2024
- Record count: 165
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,322.28 across 59 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,322.28 | 59 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $234.67 | 12 |
| Merck Sharp & Dohme Corporation | $115.94 | 5 |
| Gilead Sciences, Inc. | $111.33 | 1 |
| EISAI INC. | $105.81 | 5 |
| Daiichi Sankyo Inc. | $102.09 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $57.09 | 3 |
| Janssen Biotech, Inc. | $57.09 | 3 |
| Regeneron Healthcare Solutions, Inc. | $45.23 | 2 |
| Alexion Pharmaceuticals, Inc. | $42.95 | 2 |
| Acerta Pharma LLC | $40.10 | 2 |
| ABBVIE INC. | $39.92 | 2 |
| Astellas Pharma US Inc | $39.41 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $27.96 | 1 |
| Mirati Therapeutics, Inc. | $25.53 | 1 |
| Genentech USA, Inc. | $22.82 | 1 |
| JAZZ PHARMACEUTICALS INC. | $22.60 | 1 |
| Lilly USA, LLC | $22.44 | 1 |
| Spectrum Pharmaceuticals Inc. | $22.43 | 1 |
| Acrotech Biopharma Inc. | $21.72 | 1 |
| Geron Corporation | $21.41 | 1 |
| Incyte Corporation | $20.66 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $19.22 | 1 |
| Deciphera Pharmaceuticals Inc. | $18.78 | 1 |
| Karyopharm Therapeutics Inc. | $18.70 | 1 |
| GENZYME CORPORATION | $18.17 | 1 |
| TAIHO ONCOLOGY, INC. | $17.44 | 1 |
| Stemline Therapeutics Inc. | $15.73 | 1 |
| TerSera Therapeutics LLC | $15.04 | 1 |
By program year
Records — PY2024 (59)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.